Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What Are Wall Street Analysts' Target Price for Cencora Stock?

Pennsylvania-based Cencora, Inc. (COR) is a leading global pharmaceutical distribution and healthcare solutions company. It connects drug manufacturers with pharmacies, hospitals, and healthcare providers worldwide. With a market cap of approximately $70.5 billion, the company distributes brand, generic, and specialty medicines and also offers logistics, data, and commercialization services. 

The pharma distributor has significantly outperformed the broader market over the past year. COR stock has soared 46.6% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 15.6% gains. In 2026, the stock is up 7.6%, surpassing the index’s 1.7% rise. 

Fundamentals

See More
  • Market Capitalization, $K 69,837,480
  • Shares Outstanding, K 193,993
  • Annual Sales, $ 321,333 M
  • Annual Income, $ 1,554 M
  • EBIT $ 4,440 M
  • EBITDA $ 5,508 M
  • 60-Month Beta 0.68
  • Price/Sales 0.22
  • Price/Cash Flow 16.62
  • Price/Book 33.25

Options Overview Details

View History
  • Implied Volatility 24.73% (+1.56%)
  • Historical Volatility 36.53%
  • IV Percentile 52%
  • IV Rank 33.57%
  • IV High 36.68% on 04/08/25
  • IV Low 18.69% on 02/18/25
  • Expected Move (DTE 9) 30.83 (8.56%)
  • Put/Call Vol Ratio 0.63
  • Today's Volume 351
  • Volume Avg (30-Day) 731
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 16,373
  • Open Int (30-Day) 18,357
  • Expected Range 329.17 to 390.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 4.82
  • Number of Estimates 7
  • High Estimate 4.98
  • Low Estimate 4.70
  • Prior Year 4.42
  • Growth Rate Est. (year over year) +9.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
328.01 +9.75%
on 02/04/26
367.28 -1.98%
on 02/09/26
+24.31 (+7.24%)
since 01/09/26
3-Month
328.01 +9.75%
on 02/04/26
377.54 -4.65%
on 11/25/25
-4.65 (-1.28%)
since 11/10/25
52-Week
237.71 +51.45%
on 02/18/25
377.54 -4.65%
on 11/25/25
+113.62 (+46.12%)
since 02/10/25

Most Recent Stories

More News
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056

Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029 (the “2029 Notes”), $500 million aggregate principal...

COR : 360.00 (-0.90%)
What Are Wall Street Analysts' Target Price for Cencora Stock?

Cencora has consistently outperformed the broader market over the past year, and analysts are maintaining a strongly bullish outlook on the company’s growth and earnings potential.

$SPX : 6,941.81 (-0.33%)
COR : 360.00 (-0.90%)
PPH : 109.65 (-0.19%)
Cencora (COR) Stock Trades Up, Here Is Why

Cencora (COR) Stock Trades Up, Here Is Why

COR : 360.00 (-0.90%)
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts

COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts

COR : 360.00 (-0.90%)
Broader Market Falls as Chipmakers and AI Stocks Tumble

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.77%. March E-mini...

MSTR : 133.00 (-3.93%)
AMAT : 329.07 (-0.45%)
TROW : 96.64 (+0.87%)
AVGO : 340.44 (-1.02%)
SNDK : 541.64 (-7.16%)
GLXY : 21.19 (+0.19%)
FTV : 61.92 (+2.01%)
$IUXX : 25,127.64 (-0.56%)
COIN : 162.51 (-2.83%)
ASML : 1,413.62 (-1.11%)
ZNH26 : 112-185 (+0.06%)
ESH26 : 6,965.75 (+0.06%)
Rotation out of Tech Stocks Weighs on the Broader Market

The S&P 500 Index ($SPX ) (SPY ) today is down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.05%. March E-mini S&P futures (ESH26...

MSTR : 133.00 (-3.93%)
AMAT : 329.07 (-0.45%)
TROW : 96.64 (+0.87%)
AVGO : 340.44 (-1.02%)
SNDK : 541.64 (-7.16%)
GLXY : 21.19 (+0.19%)
FTV : 61.92 (+2.01%)
$IUXX : 25,127.64 (-0.56%)
COIN : 162.51 (-2.83%)
ASML : 1,413.62 (-1.11%)
ZNH26 : 112-185 (+0.06%)
ESH26 : 6,965.75 (+0.06%)
Stocks Mixed on Sector Rotation out of Tech

The S&P 500 Index ($SPX ) (SPY ) today is up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.56%. March E-mini S&P futures (ESH26...

TROW : 96.64 (+0.87%)
INTU : 421.39 (-3.68%)
FTV : 61.92 (+2.01%)
TRI : 90.86 (+1.74%)
$IUXX : 25,127.64 (-0.56%)
LITE : 561.13 (-2.78%)
ZNH26 : 112-185 (+0.06%)
ESH26 : 6,965.75 (+0.06%)
FDS : 204.81 (+0.78%)
LLY : 1,025.00 (-1.88%)
AMD : 213.57 (-1.12%)
$DOWI : 50,188.14 (+0.10%)
Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates

Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates

COR : 360.00 (-0.90%)
Cencora: Fiscal Q1 Earnings Snapshot

Cencora: Fiscal Q1 Earnings Snapshot

COR : 360.00 (-0.90%)
Cencora Reports Fiscal 2026 First Quarter Results

Revenue of $85.9 billion for the First Quarter, a 5.5% Increase Year-Over-Year First Quarter GAAP Diluted EPS of $2.87 and Adjusted Diluted EPS of $4.08 ...

COR : 360.00 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 369.19
2nd Resistance Point 366.65
1st Resistance Point 363.32
Last Price 360.00
1st Support Level 357.45
2nd Support Level 354.91
3rd Support Level 351.58

See More

52-Week High 377.54
Last Price 360.00
Fibonacci 61.8% 324.12
Fibonacci 50% 307.63
Fibonacci 38.2% 291.13
52-Week Low 237.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar